Literature DB >> 22492668

Serum lipids and lipoproteins in Chinese men and women.

Wenying Yang1, Jianzhong Xiao, Zhaojun Yang, Linong Ji, Weiping Jia, Jianping Weng, Juming Lu, Zhongyan Shan, Jie Liu, Haoming Tian, Qiuhe Ji, Dalong Zhu, Jiapu Ge, Lixiang Lin, Li Chen, Xiaohui Guo, Zhigang Zhao, Qiang Li, Zhiguang Zhou, Guangliang Shan, Jiang He.   

Abstract

BACKGROUND: Because of rapid change in lifestyle risk factors, cardiovascular disease has become the leading cause of death in China. We sought to estimate the national levels of serum lipids and lipoproteins among the Chinese adult population. METHODS AND
RESULTS: We conducted a cross-sectional study in a nationally representative sample of 46 239 adults aged ≥20 years. Fasting serum total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were measured by standard methods. The age-standardized estimates of total, high-density lipoprotein, and low-density lipoprotein cholesterol and triglycerides were 4.72 (95% confidence interval, 4.70-4.73), 1.30 (1.29-1.30), 2.68 (2.67-2.70), and 1.57 (1.55-1.58) mmol/L, respectively, in the Chinese adult population. In addition, 22.5% (21.8-23.3%) or 220.4 million (212.1-228.8) Chinese adults had borderline high total cholesterol (5.18-6.21 mmol/L), and 9.0% (8.5-9.5%) or 88.1 million (83.4-92.8) had high total cholesterol (≥6.22 mmol/L). The population estimates for borderline high (3.37-4.13 mmol/L), high (4.14-4.91 mmol/L), and very high (≥4.92 mmol/L) low-density lipoprotein cholesterol were 13.9% (13.3-14.5%) or 133.5 million (127.0-140.1), 3.5% (3.3-3.8%) or 33.8 million (31.2-36.5), and 3.0% (2.8-3.3%) or 29.0 million (26.3-31.8) persons, respectively. In addition, 22.3% (21.6-23.1%) or 214.9 million (207.0-222.8) persons had low high-density lipoprotein cholesterol (<1.04 mmol/L). The awareness, treatment, and control of borderline high or high total cholesterol were 11.0%, 5.1%, and 2.8%, respectively, in the Chinese adult population.
CONCLUSIONS: Serum total and low-density lipoprotein cholesterol levels were high and increasing in the Chinese population. Without effective intervention, atherosclerotic cardiovascular diseases may soar in the near future in China.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492668     DOI: 10.1161/CIRCULATIONAHA.111.065904

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  72 in total

1.  Outline of the report on cardiovascular diseases in China, 2014.

Authors:  Chen Weiwei; Gao Runlin; Liu Lisheng; Zhu Manlu; Wang Wen; Wang Yongjun; Wu Zhaosu; Li Huijun; Zheng Zhe; Jiang Lixin; Hu Shengshou
Journal:  Eur Heart J Suppl       Date:  2016-05-24       Impact factor: 1.803

2.  Blocking FSH inhibits hepatic cholesterol biosynthesis and reduces serum cholesterol.

Authors:  Yanjing Guo; Meng Zhao; Tao Bo; Shizhan Ma; Zhongshang Yuan; Wenbin Chen; Zhao He; Xu Hou; Jun Liu; Zhenhai Zhang; Qiang Zhu; Qiangxiu Wang; Xiaoyan Lin; Zhongli Yang; Min Cui; Lu Liu; Yujie Li; Chunxiao Yu; Xiaoyi Qi; Qian Wang; Haiqing Zhang; Qingbo Guan; Lifang Zhao; Shimeng Xuan; Huili Yan; Yanliang Lin; Li Wang; Qihang Li; Yongfeng Song; Ling Gao; Jiajun Zhao
Journal:  Cell Res       Date:  2018-12-17       Impact factor: 25.617

Review 3.  Blood Lipid Concentrations and Colorectal Adenomas: A Systematic Review and Meta-Analysis of Colonoscopy Studies in Asia, 2000-2014.

Authors:  Michael N Passarelli; Polly A Newcomb
Journal:  Am J Epidemiol       Date:  2016-03-24       Impact factor: 4.897

Review 4.  Cardiovascular diseases and risk factors among Chinese immigrants.

Authors:  Zhizhong Gong; Dong Zhao
Journal:  Intern Emerg Med       Date:  2015-09-08       Impact factor: 3.397

5.  Lipid profile and thyroid hormone status in the last trimester of pregnancy in single-humped camels (Camelus dromedarius).

Authors:  Arash Omidi; Zhila Sajedi; Mohammad Bagher Montazer Torbati; Hossein Ansari Nik
Journal:  Trop Anim Health Prod       Date:  2014-01-16       Impact factor: 1.559

Review 6.  Prevention and Control of Cardiovascular Disease in the Rapidly Changing Economy of China.

Authors:  Yangfeng Wu; Emelia J Benjamin; Stephen MacMahon
Journal:  Circulation       Date:  2016-06-14       Impact factor: 29.690

7.  Prescription of statins at discharge and 1-year risk of major clinical outcomes among acute coronary syndromes patients with extremely low LDL-cholesterol in clinical pathways for acute coronary syndromes studies.

Authors:  Yihong Sun; Gaoqiang Xie; Anushka Patel; Shenshen Li; Wei Zhao; Xingzi Yang; Tao Wu; Min Li; Xian Li; Xin Du; Rong Hu; Yong Huo; Dayi Hu; Run Ling Gao; Yangfeng Wu
Journal:  Clin Cardiol       Date:  2018-09-22       Impact factor: 2.882

8.  Cholesterol lipoproteins and prevalence of dyslipidemias in urban Asian Indians: a cross sectional study.

Authors:  Soneil Guptha; Rajeev Gupta; Prakash Deedwania; Anil Bhansali; Anuj Maheshwari; Arvind Gupta; Balkishan Gupta; Banshi Saboo; Jitendra Singh; Vijay Achari; Krishna Kumar Sharma
Journal:  Indian Heart J       Date:  2014-04-16

9.  Risk Prediction of Dyslipidemia for Chinese Han Adults Using Random Forest Survival Model.

Authors:  Xiaoshuai Zhang; Fang Tang; Jiadong Ji; Wenting Han; Peng Lu
Journal:  Clin Epidemiol       Date:  2019-12-10       Impact factor: 4.790

10.  Awareness, treatment, control, and determinants of dyslipidemia among adults in China.

Authors:  Sampson Opoku; Yong Gan; Emmanuel Addo Yobo; David Tenkorang-Twum; Wei Yue; Zhihong Wang; Zuxun Lu
Journal:  Sci Rep       Date:  2021-05-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.